レポートナンバー 0000033831
アメリカ・カナダ・メキシコにおける感染症検査の北アメリカ市場 - 2022年の検査別サプライヤーシェア、2022年から2027年の病院、商用/民間ラボ、POCで実施される100の呼吸器、STD、腸内、およびその他のウイルス学、細菌学、寄生虫学、菌学アッセイのセグメンテーション予測 - 競合戦略とSWOT分析、最新技術、計装パイプライン、市場の障壁とリスク
VPGMarketResearch
North America Infectious Disease Testing Market in the US, Canada and Mexico--2022 Supplier Shares by Test, 2022-2027 Segmentation Forecasts for 100 Respiratory, STD, Enteric, and other Virology, Bacteriology, Parasitology and Mycology Assays Performed in Hospitals, Commercial/Private Labs, POC Locations--Competitive Strategies and SWOT Analysis, Latest Technologies, Instrumentation Pipeline, Market Barriers and Risks
発刊日
2022/12/14
言語英語
体裁PDF
レポート概要
本レポートは、100の個別検査の検査量と売上予測、競合他社の戦略など、他のソースでは入手できないデータと分析結果を提供します。本調査は、ダイナミックかつ急速に拡大する感染症検査市場への参入を計画している企業や診断薬業界の幹部が、新たな機会を評価し、効果的なビジネス戦略を策定する際に役立つよう作成されています。
本レポートはセクションごとに用意されており、特定の情報ニーズや予算に応じてカスタマイズすることができます。
本レポートでは、100種類以上の微生物検査について、きめ細かい市場細分化分析と予測を行い、革新的な技術や製品を持つ主要サプライヤーや最近の市場参入者を紹介し、現在の機器のレビュー、新しい技術の評価、サプライヤーに対する具体的な機会や戦略の提案を行っています。
論理的根拠
本レポートは、診断業界の経営者や、ダイナミックかつ急速に拡大する感染症検査市場への参入を計画している企業にとって、新たなビジネスチャンスの評価と効果的なビジネス戦略の立案に役立つものです。
感染症検査は、体外診断業界で最も急速に成長している分野の 1 つであり、この 10 年間にサプライヤーが直面する最大の課題です。その主な推進要因は、依然として世界的な健康上の脅威であり、日和見感染症の増加の主な要因であるエイズ（AIDS）の継続的な拡大、バイオテロの脅威、分子診断技術の進歩、免疫抑制剤の利用可能性の拡大などです。感染症には、その原因が未だ解明されていないものもあれば、臨床症状が現れるずっと前から微量に存在するものもあるが、近年の遺伝子工学や検出技術の進歩により、高感度、特異性、費用対効果の高い製品を生み出すエキサイティングな機会が生まれています。
調査範囲
• 本レポートで分析した感染症検査
AIDS/HIV、アデノウイルス、アエロモナス菌、バルトネラ菌、ヒト芽胞菌、カンピロバクター、カンジダ、カルバペネマーゼ、下疳、クラミジア、クロストリジウム、コロナウイルス、コクサッキーウイルス、クリプトスポリジウム、サイクロスポラ、CMV、大腸菌、エコーウイルス、脳炎、エンテロウイルス、EBV、ジアルジア、淋病 、鼠径肉芽腫、ハンタウイルス、ピロリ菌、肝炎、インフルエンザヘルペス、レジオネラ、ライム病、リンパ肉芽腫、マラリア、麻疹、髄膜炎、小胞子虫、単核症、おたふくかぜ、マイコプラズマ、ノロウイルス、HPV、パルボウイルス、肺炎、ポリオーマウイルス、シュードモナス、狂犬病、 RSV、ライノウイルス、ロタウイルス、風疹、サルモネラ、敗血症、赤痢菌、ブドウ球菌、連鎖球菌、梅毒、トキソプラズマ症、トリコモナス、結核、ビブリオ、西ナイル、エルシニア
• 調査国
➣ カナダ
➣ メキシコ
➣ アメリカ
• 市場セグメント分析
➣ 主要国における感染症診断製品の主要サプライヤーの検査別の売上と市場シェア
➣ 100種類の感染症診断アッセイの国別、個別検査別、市場セグメント別の検査・売上予測
➣ 市場の力学、動向、構造、規模、成長、主要サプライヤーのレビュー
• 現行製品および新製品
➣ 病因、現在の診断検査、ワクチン、治療薬、市場のニーズなど、主要な疾患の詳細な調査
➣ 感染症検査に使用される主な分析装置の動作特性や特徴、販売価格などのレビュー
• 技術レビュー
➣ 新しい診断技術の評価と感染症検査への応用の可能性
➣ 感染症診断製品を個別検査別に開発・販売している企業
• 競合評価
➣ 主要サプライヤーおよび新興市場参入企業の戦略的評価（売上、製品ポートフォリオ、マーケティング戦術、提携関係、研究開発中の新製品など）
• サプライヤーにとっての機会と戦略
➣ 今後5年間に市場に大きな訴求力を持つ新しい機器、試薬システム、ITおよびその他の製品に関する新たな機会。
➣ 分散型検査製品の設計基準
➣ 市場浸透のための代替戦略
➣ 潜在的な市場参入障壁とリスク
レポート詳細
目次
Table of Contents
I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Overview of Major Tests, Technologies and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Carbapenemase
13. Chagas Disease
14. Chancroid
15. Chlamydia
16. Clostridium Difficile
17. Coronaviruses
18. Coxsackieviruses
19. Creutzfeldt-Jakob’s Disease
20. Cryptosporidium Parvum
21. Cyclospora Cayetanensis
22. Cytomegalovirus
23. Ebola Virus
24. E. Coli
25. Echovirus
26. Encephalitis
27. Enteroviruses
28. Epstein-Barr Virus
30. Giardia Lamblia
31. Gonorrhea
32. Granuloma Inguinale
33. Hantavirus
34. Helicobacter Pylori
35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
36. Herpes Simplex Virus
37. Human Herpes Virus-6 (HHV-6)
38. Influenza Viruses
39. Legionella
40. Lyme Disease
41. Lymphogranuloma Venereum (LGV)
42. Malaria
43. Measles (Rubeola)
44. Meningitis
45. Microsporidium
46. Mononucleosis
47. Mumps
48. Mycoplasma
49. Norovirus
50. Papillomaviruses
51. Parvovirus B19
52. Pneumonia
53. Polyomaviruses
54. Pseudomonas Aeruginosa
55. Rabies
56. Respiratory Syncytial Virus (RSV)
57. Rhinoviruses
58. Rotavirus
59. Rubella
60. Salmonellosis
61. Septicemia
62. Shigellosis
63. Staphylococcus Aureus
64. Streptococci
65. Syphilis
66. Toxoplasmosis
67. Trichomonas Vaginalis
68. Tuberculosis
69. Vibrio
70. West Nile Virus
71. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VII. Country Analyses: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares
- Canada
- Mexico
- USA
VIII. Competitive Assessments
- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Decode Genetics
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujifilm Wako
- Fujirebio
- Grifols
- Hologic
- Illumina
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- OrthoQuidel
- PerkinElmer
- Proteome Sciences
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Sequenom/LabCorp
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
List of Tables
Canada
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Canada
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Mexico
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Mexico
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Laboratories Performing Infectious Disease
Tests by Market Segment
U.S.A.
Hospital Laboratories Performing Infectious
Disease Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious
Disease Tests by Practice Size
U.S.A.
All Market Segments Infectious Disease
Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease
Test Volume by Method
U.S.A.
Hospital Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Blood Banks Infectious Disease
Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease
Diagnostics Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Blood Banks Infectious Disease
Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
HIV or HIV I/HIV II/Combo Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HIVAg Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Adenovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
BEA Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Blastocystis Hominis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Campylobacter Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Candida Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Carbapenemase Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Chancroid Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Chlamydia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Clostridium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Coronavirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
CoxsackieVirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
CMV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Echovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Encephalitis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Enterovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
EBV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Giardia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Hantavirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
HAV NAT Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBV NAT Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HbsAg Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HCV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HCV NAT Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Hepatitis C Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Anti-HBC Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Anti-HBS Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Anti-HAV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBcAg Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBeAg Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
ALT/SGPT Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Influenza Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Legionella Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Lymphogranuloma Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Malaria Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Measles Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Meningitis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Microsporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Mononucleosis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Mumps Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Mycoplasma Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Norovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Papilloma Virus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Parvovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Pneumonia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Polyomaviruses Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Pseudomonas Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Rabies
Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
RSV Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Rhinovirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Rotavirus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Rubella Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Salmonella Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Septicemia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Shigella Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Staphylococci Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Streptococci Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Trichomonas Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Tuberculosis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Vibrio Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
West Nile Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Yersinia Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
AIDS Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Adenovirus Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Candida Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Carbapenemase Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Chancroid Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Chlamydia Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
CMV Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Cryptosporidium Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Echovirus Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
EBV Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Giardia Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Gonorrhea Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Herpes Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Influenza Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Legionella Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Lyme Disease Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Measles Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Mumps Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Norovirus Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Rabies Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
RSV Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Rotavirus Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Rubella Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Salmonella Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Shigella Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Streptococci Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics
Sales by Major Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics
Sales by Major Supplier
Major Companies Developing or
Marketing AIDS Tests
Major Companies Developing or
Marketing Adenovirus Tests
Major Companies Developing or
Marketing Bartonella Tests
Major Companies Developing or
Marketing Campylobacter Tests
Major Companies Developing or
Marketing Candida Tests
Major Companies Developing or
Marketing Carbapenemase Tests
Major Companies Developing or
Marketing Chlamydia Tests
Major Companies Developing or
Marketing Clostridium Tests
Major Companies Developing or
Marketing Coronavirus Tests
Major Companies Developing or
Marketing Cryptosporidium Tests
Major Companies Developing or
Marketing CMV Tests
Major Companies Developing or
Marketing Echovirus Tests
Major Companies Developing or
Marketing Enterovirus Tests
Major Companies Developing or
Marketing EBV Tests
Major Companies Developing or
Marketing Giardia Tests
Major Companies Developing or
Marketing Gonorrhea Tests
Major Companies Developing or
Marketing Hantavirus Tests
Major Companies Developing or
Marketing Helicobacter Pylori Tests
Major Companies Developing or
Marketing Hepatitis Tests
Major Companies Developing or
Marketing Herpes Tests
Major Companies Developing or
Marketing Influenza Tests
Major Companies Developing or
Marketing Legionella Tests
Major Companies Developing or
Marketing Lyme Disease Tests
Major Companies Developing or
Marketing Lymphogranuloma Tests
Major Companies Developing or
Marketing Malaria Tests
Major Companies Developing or
Marketing Measles Tests
Major Companies Developing or
Marketing Meningitis Tests
Major Companies Developing or
Marketing Microsporidium Tests
Major Companies Developing or
Marketing Mononucleosis Tests
Major Companies Developing or
Marketing Mumps Tests
Major Companies Developing or
Marketing Mycoplasma Tests
Major Companies Developing or
Marketing Norovirus Tests
Major Companies Developing or
Marketing Papilloma Virus Tests
Major Companies Developing or
Marketing Parvovirus Tests
Major Companies Developing or
Marketing Pneumonia Tests
Major Companies Developing or
Marketing RSV Tests
Major Companies Developing or
Marketing Rotavirus Tests
Major Companies Developing or
Marketing Rubella Tests
Major Companies Developing or
Marketing Salmonella Tests
Major Companies Developing or
Marketing Septicemia Tests
Major Companies Developing or
Marketing Shigella Tests
Major Companies Developing or
Marketing Staphylococci Tests
Major Companies Developing or
Marketing Streptococci Tests
Major Companies Developing or
Marketing Syphilis Tests
Major Companies Developing or
Marketing Toxoplasmosis Tests
Major Companies Developing or
Marketing Trichomonas Tests
Major Companies Developing or
Marketing Tuberculosis Tests
Major Companies Developing or
Marketing West Nile Tests
Major Companies Developing or
Marketing Yersinia Tests
